I'm LongbridgeAI, I can summarize articles.The Week
STM closed the week down 9.08% at $52.06, against $57.26 the previous Friday. Over the same stretch, the S&P 500 added 1.15%, leaving the stock about 10.23 percentage points behind. The week followed a fade-from-the-open shape: it started Monday at $56.60, peaked Tuesday near $59.29, then slid for three straight sessions. Thursday hit $52.14 and Friday marked the week’s low at $51.73 before settling at $52.06. Amplitude came to 13.36%, with average daily turnover of roughly 8.9m shares, modestly above the 60-day median.
Key Events
The clearest company-specific item was the confirmation on Monday of its Q3 2026 earnings date: results and the call are scheduled for 29 October before the open, giving the market a concrete check point. From Wednesday the stock moved lower, and several intraday headlines tied the decline to broader weakness in European chip names. Midweek, EDGE AI FOUNDATION announced three new working groups and a partnership with LF Edge, with STMicroelectronics referenced among the participants, though that did not shift the week’s downward tone.
Analyst Ratings
Coverage stands at 14 brokers: 7 rate the stock buy, 1 overweight and 6 hold, with no sell or underweight calls. The consensus rating is buy, and the consensus target of $75.04 sits about 44.14% above the week’s close of $52.06. Targets range from $52.00 to $98.00, a spread of roughly $46 that points to wide disagreement among analysts. Within the semiconductor maker industry, STM’s coverage size ranks 27th, below the industry mean of 14 and median of 9 names.
The Week Ahead
US macro data comes in thick next week: NFIB small business optimism and existing home sales on 13 October, followed by multiple CPI and core CPI prints on 14 October that will bear directly on the rate path debate. The company’s Q3 release on 29 October — with consensus estimates around $0.40 EPS and $3.74bn revenue — is the first hard check after the earnings date was set this week.
In Short
This week’s tension sits between a still-positive sell-side view and the market’s own repricing. Most brokers rate the stock buy and the consensus target stands more than 40% above spot, yet the shares faded after an early pop, and the latest session’s large-lot money was a small net seller while mid and small flows were mixed. Valuation is extended at about 99.7x earnings and 2.63x book. The near-term tests are the US CPI on 14 October and the company’s results on 29 October: the former sets the pace for sector-wide multiple compression, the latter shows whether current earnings expectations can hold up.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.
